The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique
NCT ID: NCT03820362
Last Updated: 2019-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
85 participants
OBSERVATIONAL
2016-02-29
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581
Imagery Rescripting as a Treatment for Early Psychosis
NCT06539780
Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia
NCT01295411
Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study
NCT00350935
Improving Accessibility and Personalization of CR for Schizophrenia
NCT03576976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition, current psychological models of positive and negative symptoms highlight the influence of neurocognition, social cognition and self-concepts in the development and maintenance of psychotic experiences. Despite the recognized need of person-centered approaches to understand psychopathology processes in psychosis, psychological models for explaining psychotic symptoms have not explored sufficiently the role of this kind of person-centered measures.
Aim
1\. To examine the influence of the structure of personal identity and other relevant cognitive factors in positive and negative symptoms
Hypotheses
1. Positive symptoms will be influenced by dichotomous thinking style and construction of self as measured with the RGT.
2. Negative symptoms will be affected by the richness of the construct system as measured with the RGT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 18 and 60 years.
* patients from outpatient mental health units
Exclusion Criteria
* current substance dependence
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc Sanitari Sant Joan de Déu
OTHER
Agència de Gestió d'Ajuts Universitaris i de Recerca, Catalunya, Spain
UNKNOWN
Ministerio de Educación y Formación Profesional, Spain
UNKNOWN
University of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helena García Mieres
M.Sc., Ph.D. Cand.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena García-Mieres, MsC
Role: PRINCIPAL_INVESTIGATOR
Universitat de Barcelona & Parc Sanitari Sant Joan de Déu
Susana Ochoa, PhD
Role: STUDY_DIRECTOR
Parc Sanitari Sant Joan de Déu
Guillem Feixas, PhD
Role: STUDY_DIRECTOR
University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parc Sanitary Sant Joan de Déu
Sant Boi de Llobregat, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FPU15/01721
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.